HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Acquisition of CB Fleet drives up Prestige OTC

This article was originally published in OTC Bulletin & The Rose Sheet

Executive Summary

“Continued strong consumption levels” across its portfolio, plus the acquisition of CB Fleet last year, helped push up sales at Prestige Brands’ North American OTC Healthcare unit by 20.5% to US$869 million (€738 million) in the 12 months ended 31 March 2018, reported the firm’s chief executive officer Ron Lombardi.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

RS122209

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel